A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus

• Status: Terminated
• Trial end date: 2008-02-19
• Target enrollment: 0
• Participant gender: All

Summary

To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Diabetes mellitus type 2

• Failing two or more oral anti-diabetic agents

Exclusion Criteria:

• Asthma, COPD

• Smoking